Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0432222 (
SEM
)
47,337
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Extra-large-pore aluminophosphate -CLO (i.e.,
DNL
-1) nanocrystals were synthesized in a eutectic mixture composed of diethylamine hydrochloride (DEAC) and ethylene glycol (EG) with 1-methylimidazole (1-MIm) as an additional amine using both conventional and microwave heating. The effects of the synthesis parameters, such as the amount of 1-MIm and the P/Al ratio, on the formation of
DNL
-1 nanocrystals were studied. The products were characterized using a variety of techniques. XRD, DLS,
SEM
and TEM results indicate that the as-synthesized
DNL
-1 nanocrystals have good crystallinity and narrow particle size distributions, and their average particle size was controlled in the 100-220nm range by simply adjusting the amount of 1-MIm. TG-DSC and N2 adsorption analyses reveal that the as-synthesized
DNL
-1 nanocrystals exhibit good thermal stability and the calcined samples possess high BET surface areas and large pore volumes. In addition, the cooperative structure-directing effects of 1-MIm and the eutectic mixture cation (DEA(+)) in the formation of
DNL
-1 nanocrystals were discussed.
...
PMID:Synthesis of discrete aluminophosphate -CLO nanocrystals in a eutectic mixture. 2589 47